Published in Can Urol Assoc J on April 01, 2012
Prevention of sepsis prior to prostate biopsy. Investig Clin Urol (2016) 0.75
Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy. Eur J Clin Microbiol Infect Dis (2015) 0.75
Location, location, location: Prostate biopsies and MRIs. Can Urol Assoc J (2012) 0.75
Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link. Can Urol Assoc J (2013) 0.75
The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain (1983) 7.46
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol (2006) 3.53
Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev (2011) 2.12
Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int (2000) 1.83
Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol (2001) 1.79
Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology (1998) 1.57
CUA guidelines on prostate biopsy methodology. Can Urol Assoc J (2010) 1.44
Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother (2008) 1.34
Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology (2007) 1.29
A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol (2004) 1.03
Evaluation of needle size for breast biopsy: comparison of 14-, 16-, and 18-gauge biopsy needles. AJR Am J Roentgenol (1998) 0.91
Does needle calibre affect pain and complication rates in patients undergoing transperineal prostate biopsy? A prospective, randomized trial. Asian J Androl (2009) 0.89
Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies. Prostate Cancer Prostatic Dis (2008) 0.87
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol (2007) 4.37
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys (2010) 3.06
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy. Urology (2011) 2.20
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol (2007) 2.16
GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study. Urology (2013) 2.09
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection. J Urol (2010) 2.05
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol (2007) 2.02
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol (2006) 2.02
Development and external validation of an extended 10-core biopsy nomogram. Eur Urol (2006) 1.90
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology (2007) 1.83
Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy. J Am Soc Nephrol (2010) 1.70
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int (2007) 1.68
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol (2007) 1.65
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int (2012) 1.64
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. Eur Urol (2007) 1.62
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Mod Pathol (2009) 1.61
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol (2009) 1.61
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Urology (2009) 1.58
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis. Eur Urol (2011) 1.57
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial. BJU Int (2013) 1.52
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study. Can Urol Assoc J (2009) 1.51
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol (2005) 1.45
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma. Ann Surg Oncol (2010) 1.43
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Urology (2009) 1.42
Outcomes research: a methodologic review. Eur Urol (2006) 1.39
A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol (2009) 1.35
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol (2009) 1.33
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. BJU Int (2008) 1.18
Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol (2006) 1.13
Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. J Urol (2011) 1.11
Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer (2011) 1.06
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol (2009) 1.06
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma. Mod Pathol (2009) 1.06
Incidence of priapism in emergency departments in the United States. J Urol (2013) 1.05
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. Urology (2009) 1.04
The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int (2005) 1.00
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer (2010) 1.00
Development and external validation of an extended repeat biopsy nomogram. J Urol (2007) 1.00
Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer (2011) 0.99
GreenLight 180W XPS photovaporization of the prostate: how I do it. Can J Urol (2011) 0.98
Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int (2008) 0.98
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology (2009) 0.98
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur J Cancer (2007) 0.94
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.94
Return to continence after radical retropubic prostatectomy: a randomized trial of verbal and written instructions versus therapist-directed pelvic floor muscle therapy. Urology (2008) 0.94
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma. J Urol (2010) 0.94
Age-related changes in prefrontal cortex activity are associated with behavioural deficits in both temporal and spatial context memory retrieval in older adults. Cortex (2009) 0.94
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU Int (2006) 0.93
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec. Can J Urol (2005) 0.93
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. Eur J Cancer (2006) 0.93
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma. Clin Cancer Res (2009) 0.93
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors. Urology (2009) 0.92
Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation. J Immunol Methods (2011) 0.91
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. BJU Int (2007) 0.91
A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis. Cancer Causes Control (2012) 0.90
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA. BJU Int (2011) 0.90
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol (2009) 0.89
Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence. J Urol (2009) 0.89
p53 inhibits angiogenesis by inducing the production of Arresten. Cancer Res (2012) 0.89
The effect of insurance status on outcomes after partial nephrectomy. Int Urol Nephrol (2011) 0.87
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU Int (2011) 0.87
Childhood trauma and dissociation in first-episode psychosis, chronic schizophrenia and community controls. Psychiatry Res (2013) 0.86
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study. Ann Surg Oncol (2010) 0.86
Prediction of delayed graft function after renal transplantation. Can Urol Assoc J (2009) 0.86
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int (2007) 0.86
Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study. Ann Surg Oncol (2011) 0.85
Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology (2004) 0.83
IκB-Kinase-ε (IKKε/IKKi/IκBKε) expression and localization in prostate cancer tissues. Prostate (2011) 0.82
Management of radial scars found at percutaneous breast biopsy. Can Assoc Radiol J (2006) 0.82
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Eur Urol (2006) 0.81
Validation of prostate cancer index and SF-12 short forms. Can J Urol (2005) 0.81
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients. Can J Urol (2005) 0.81
A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses. BJU Int (2009) 0.81
Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma. J Trauma (2008) 0.81
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. Ann Surg Oncol (2011) 0.81
Managing adults with urinary incontinence. Clinical practice guidelines. Can Fam Physician (2002) 0.80
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer. BJU Int (2006) 0.80
Training and outcome monitoring in robotic urologic surgery. Nat Rev Urol (2011) 0.80
Therapeutic approach to hormone-refractory prostate cancer. Can J Urol (2006) 0.80
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. BJU Int (2011) 0.79
Does partial nephrectomy at an academic institution result in better outcomes? World J Urol (2011) 0.79
Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease. Metabolism (2005) 0.79
Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment. Rare Tumors (2012) 0.79
Development and internal validation of preoperative transition zone prostate cancer nomogram. Urology (2006) 0.79
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men. Int J Urol (2008) 0.79
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort. Urology (2009) 0.78
Screening men for prostate cancer and colorectal cancer: is practice evidence-based? Can J Urol (2007) 0.78
Creation and testing of the Geriatric Self-Efficacy Index for Urinary Incontinence. J Am Geriatr Soc (2008) 0.78
Ejaculatory disorders may affect screening for prostate cancer. J Urol (2007) 0.78